Inhibition of CD36 ameliorates mouse spinal cord injury by accelerating microglial lipophagy.

Spinal cord injury (SCI) is a serious trauma of the central nervous system (CNS). SCI induces a unique lipid-dense environment that results in the deposition of large amounts of lipid droplets (LDs). The presence of LDs has been shown to contribute to the progression of other diseases.

Tensor Network Computations That Capture Strict Variationality, Volume Law Behavior, and the Efficient Representation of Neural Network States.

We introduce a change of perspective on tensor network states that is defined by the computational graph of the contraction of an amplitude. The resulting class of states, which we refer to as tensor network functions, inherit the conceptual advantages of tensor network states while removing computational restrictions arising from the need to converge approximate contractions. We use tensor network functions to compute strict variational estimates of the energy on loopy graphs, analyze their expressive power for ground states, show that we can capture aspects of volume law time evolution, and provide a mapping of general feed-forward neural nets onto efficient tensor network functions.

Precise Measurement of the e^{+}e^{-}→D_{s}^{+}D_{s}^{-} Cross Section at Center-of-Mass Energies from Threshold to 4.95 GeV.

Using the e^{+}e^{-} collision data collected with the BESIII detector operating at the BEPCII collider, at center-of-mass energies from the threshold to 4.95 GeV, we present precise measurements of the cross section for the process e^{+}e^{-}→D_{s}^{+}D_{s}^{-} using a single-tag method. The resulting cross section line shape exhibits several new structures, thereby offering an input for a future coupled-channel analysis and model tests, which are critical to understand vector charmonium-like states with masses between 4 and 5 GeV.

Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2).

Objective: To optimize the construction of pharmaceutical services in medical institutions, advance the development of clinical pharmacy as a discipline, enhance the level of clinical pharmacy services, systematically implement and evaluate clinical pharmacy practices, and improve patient therapeutic outcomes, we have developed the Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (Version 2).

Methods: This guideline was designed following the World Health Organization (WHO) Guideline Development Manual. The Delphi method was employed to identify clinical questions.